Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive. 根据Gen Consulting公司最新分析, the global electrophysiology devices market is projected to climb to USD 15,946 到 2028 年底将达到 100 万, 复合年增长率为 8.9% 期间 2022-2028.

该行业报告提供了全球市场的市场预测, 接下来是对产品的详细分析, 和地区. The global market data on electrophysiology devices can be segmented by product: catheters, electrophysiology (EP) lab devices, 其他的. Electrophysiology devices market is further segmented by region: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

The catheters market is further segmented into ablation catheters, diagnostic catheters. 此外, the EP lab devices market has been categorized into 3D mapping systems, cardiac stimulators, electrophysiology (EP) recording systems, intracardiac echocardiography (冰) 系统, radiofrequency ablation generators.

The global electrophysiology devices market is highly competitive. Some of the leading companies operating in the market are Abbott Laboratories, Acutus Medical Inc., AtriCure Inc., Baylis Medical Company Inc., Biosense Webster Inc. (约翰逊 & 约翰逊), BIOTRONIK SE & 钴. 公斤, 波士顿科学公司, CardioFocus Inc., 通用电气公司, Japan Lifeline Co. 有限公司, 皇家飞利浦公司, Lepu Medical Technology (北京) 钴. 有限公司, 美敦力公司, MicroPort Scientific Corporation, OSYPKA AG, Stereotaxis Inc., Vanguard AG.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Electrophysiology Devices Market
– Identify segments/areas to invest in over the forecast period in the Global Electrophysiology Devices Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.